Covered recipient · General Payments record
GEORGE NUNEZ
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,311.90
- Reported across 176 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.64 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $51.33 | 2 |
| Celgene Corporation | $50.09 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $33.47 | 2 |
| Medtronic, Inc. | $28.82 | 1 |
| Gilead Sciences, Inc. | $25.32 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.74 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105136862 | CMS |
| ABBVIE INC. | $27.59 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105136864 | CMS |
| Celgene Corporation | $23.47 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101148334 | CMS |
| Celgene Corporation | $26.62 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101148342 | CMS |
| Gilead Sciences, Inc. | $25.32 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133787199 | CMS |
| Medtronic, Inc. | $28.82 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119275210 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $19.92 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153427355 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.55 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153588864 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.61 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137644886 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.